Abpro Holdings, Inc.
Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in di… Read more
Abpro Holdings, Inc. (ABP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.146x
Based on the latest financial reports, Abpro Holdings, Inc. (ABP) has a cash flow conversion efficiency ratio of 0.146x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.28 Million) by net assets ($-15.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Abpro Holdings, Inc. - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Abpro Holdings, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Abpro Holdings, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Abpro Holdings, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TONGDA GRP HLDGS
MU:TJC
|
N/A |
|
Vivakor Inc
NASDAQ:VIVK
|
0.176x |
|
Tarachi Gold Corp
OTCQB:TRGGF
|
-0.013x |
|
Lowland Investment Co
LSE:LWI
|
0.011x |
|
AVI Japan Opportunity Trust PLC
LSE:AJOT
|
0.004x |
|
SPACEANDPEOPLE LS-1
F:RWK0
|
N/A |
|
TREVI - Finanziaria Industriale S.p.A.
LSE:0G91
|
N/A |
|
GeoVax Labs Inc
NASDAQ:GOVX
|
-1.266x |
Annual Cash Flow Conversion Efficiency for Abpro Holdings, Inc. (2016–2024)
The table below shows the annual cash flow conversion efficiency of Abpro Holdings, Inc. from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-14.95 Million | $-9.03 Million | 0.604x | +594.90% |
| 2023-12-31 | $-85.14 Million | $-7.40 Million | 0.087x | -26.45% |
| 2022-12-31 | $-75.73 Million | $-8.95 Million | 0.118x | +103.31% |
| 2021-12-31 | $3.07 Million | $-10.95 Million | -3.566x | -945.73% |
| 2017-12-31 | $-22.46 Million | $-9.47 Million | 0.422x | +6.67% |
| 2016-12-31 | $-12.35 Million | $-4.88 Million | 0.395x | -- |